Switch to:
More From Other Websites
[video]Takeover Chatter Around Clovis May Be Overdone Sep 23 2016
'Blockbuster Franchises' Spark M&A Fever For Sarepta, Ariad, Biotechs Sep 21 2016
Is Tesaro Another M&A Target? The Charts Say It Is Sep 21 2016
Looking Ahead To The Potentially Game Changing TESARO Inc (TSRO) Data Sep 14 2016
Tesaro Gets Fast Track Designation for Ovarian Cancer Drug Sep 13 2016
TESARO, Inc. – Value Analysis (NASDAQ:TSRO) : September 12, 2016 Sep 12 2016
TESARO Receives FDA Fast Track Designation for Niraparib and Initiates Rolling NDA Submission Sep 12 2016
TESARO Receives FDA Fast Track Designation for Niraparib and Initiates Rolling NDA Submission Sep 12 2016
Gilead Sciences: What is PARP? Sep 09 2016
TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : September 9, 2016 Sep 09 2016
Clovis Oncology Up As FDA Skips Review Panel For New Drug Sep 08 2016
When Gilead Sciences Speaks… Sep 08 2016
Lake Street Says Buy-Rated Tesaro Holds An Attractive Portfolio Of Cancer Therapies Sep 06 2016
TESARO Announces Six Data Presentations at the 2016 European Society for Medical Oncology (ESMO)... Sep 06 2016
Coverage initiated on Tesaro by BofA/Merrill Aug 30 2016
TESARO Announces Participation at Four Investor Conferences Aug 24 2016
TESARO Announces Participation at Four Investor Conferences Aug 24 2016
Medivation Scores Premium in Sale to Pfizer Aug 22 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK